OrphAI Therapeutics
0 followers
About OrphAI Therapeutics
OrphAI Therapeutics is a biotech company focused on identifying and developing novel, life-saving drugs for diseases with unmet medical needs. Its current clinical-stage candidates target pulmonary hypertension (including Group 1 and Group 3 PH), bronchiolitis obliterans syndrome post-lung transplant, and transcriptionally dysregulated cancers, with a pipeline aimed at delivering therapies for patients in need. The company is headquartered in New Haven, Connecticut, and conducts early to mid-stage clinical programs to advance its drug candidates.